Invus Global Management, LLC - 29 Jan 2026 SCHEDULE 13D/A Report for Lexicon Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (LXRX)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Artal Participations S.a r.l.
Security
Lexicon Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol
LXRX
Shares outstanding
427,442,892 shares
Disclosed Ownership
154,734,327 shares
Ownership
36%
Form type
SCHEDULE 13D/A
Filing time
02 Feb 2026, 21:54:05 UTC
Date of event
29 Jan 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Invus Global Management, LLC disclosed 36% ownership in Lexicon Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (LXRX) on 29 Jan 2026."

Quick Takeaways

  • Invus Global Management, LLC filed SCHEDULE 13D/A for Lexicon Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (LXRX).
  • Disclosed ownership: 36%.
  • Date of event: 29 Jan 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 02 Feb 2026, 21:54.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (18)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus, L.P. 10% 42,765,057 35,402,689 7,362,368 /s/ Raymond Debbane Raymond Debbane, President of Invus Advisors L.L.C., its general partner 0001404570
Invus Advisors, L.L.C. 10% 42,765,057 35,402,689 7,362,368 /s/ Raymond Debbane Raymond Debbane, President
Invus Public Equities, L.P. 1.7% 7,362,368 0 7,362,368 /s/ Raymond Debbane Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 1.7% 7,362,368 0 7,362,368 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 10% 42,765,057 42,765,057 0 /s/ Raymond Debbane Raymond Debbane, President 0002005369
Siren, L.L.C. 10% 42,765,057 42,765,057 0 /s/ Raymond Debbane Raymond Debbane, President
Avicenna Life Sci Master Fund LP 0.4% 1,538,462 1,538,462 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
Avicenna Life Sci Master GP LLC 0.4% 1,538,462 1,538,462 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer
Invus US Partners LLC 1.3% 5,451,204 5,451,204 0 /s/ Raymond Debbane Raymond Debbane, President
Ulys, L.L.C. 1.6% 6,989,666 6,989,666 0 /s/ Raymond Debbane Raymond Debbane, President 0001218180
Mr. Raymond Debbane 12% 51,217,900 51,217,900 0 /s/ Raymond Debbane Raymond Debbane
Artal Participations S.a r.l. 36% 154,734,327 154,734,327 0 /s/ Pierre Claudel Pierre Claudel, Manager
Artal International S.C.A. 36% 154,734,327 154,734,327 0 /s/ Anne Goffard Anne Goffard, Managing Director of Artal International Management S.A., its managing partner
Artal International Management S.A. 36% 154,734,327 154,734,327 0 /s/ Anne Goffard Anne Goffard, Managing Director
Artal Group S.A. 36% 154,734,327 154,734,327 0 /s/ Anne Goffard Anne Goffard, Authorized Person
Westend S.A. 36% 154,734,327 154,734,327 0 /s/ Anne Goffard Anne Goffard, Managing Director
Stichting Administratiekantoor Westend 36% 154,734,327 154,734,327 0 /s/ Amaury Wittouck Amaury Wittouck, Sole Member of the Board
Mr. Amaury Wittouck 36% 154,734,327 154,734,327 0 /s/ Amaury Wittouck Amaury Wittouck

Sponsored